• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.

作者信息

Dholaria Bhagirathbhai, Radujkovic Aleksandar, Estrada-Merly Noel, Sirait Tiarlan, Kim Soyoung, Hernández-Boluda Juan Carlos, Czerw Tomasz, Hayden Patrick J, Kansagra Ankit, Ho Vincent T, Nishihori Taiga, Shaughnessy Paul, Scott Bart, Nakamura Ryotaro, Oran Betul, Kharfan-Dabaja Mohamed, Savani Bipin N, McLornan Donal, Yakoub-Agha Ibrahim, Saber Wael

机构信息

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Universitätsklinikum Heidelberg, Heidelberg, Germany.

出版信息

Br J Haematol. 2022 Aug;198(4):785-789. doi: 10.1111/bjh.18297. Epub 2022 Jun 3.

DOI:10.1111/bjh.18297
PMID:35658101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9750039/
Abstract
摘要

相似文献

1
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.慢性中性粒细胞白血病异基因造血细胞移植的结局：CIBMTR/EBMT联合CMWP分析
Br J Haematol. 2022 Aug;198(4):785-789. doi: 10.1111/bjh.18297. Epub 2022 Jun 3.
2
Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for Mutant Chronic Neutrophilic Leukemia.芦可替尼维持治疗成功用于异基因干细胞移植治疗突变型慢性中性粒细胞白血病
Turk J Haematol. 2023 Feb 28;40(1):73-74. doi: 10.4274/tjh.galenos.2022.2022.0400. Epub 2022 Dec 13.
3
Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.异基因造血干细胞移植治疗BCR-ABL1阴性非典型慢性髓性白血病和慢性中性粒细胞白血病：日本一项全国性回顾性研究
Leuk Res. 2018 Dec;75:50-57. doi: 10.1016/j.leukres.2018.11.003. Epub 2018 Nov 13.
4
T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.接受异基因干细胞移植的慢性中性粒细胞白血病和慢性粒单核细胞白血病患者中的T618I突变型集落刺激因子3受体
Ann Lab Med. 2015 May;35(3):376-8. doi: 10.3343/alm.2015.35.3.376. Epub 2015 Apr 1.
5
Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT).接受肾脏替代治疗的骨髓瘤患者的异基因造血细胞移植（allo-HCT）结果：欧洲血液与骨髓移植协会（EBMT）慢性恶性肿瘤工作组（CMWP）的报告
Bone Marrow Transplant. 2021 Mar;56(3):529-531. doi: 10.1038/s41409-020-01010-1. Epub 2020 Aug 2.
6
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).欧洲血液与骨髓移植组（EBMT）急性白血病工作组（ALWP）对50岁以上急性髓细胞白血病患者进行人类白细胞抗原（HLA）全相合同胞异基因造血干细胞移植时，减低强度预处理方案与清髓性预处理方案的比较结果：一项回顾性调查
Leukemia. 2005 Dec;19(12):2304-12. doi: 10.1038/sj.leu.2403967.
7
Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.成人复发或难治性急性髓系白血病患者序贯化疗后行减低强度预处理和异基因造血干细胞移植：来自 EBMT 急性白血病工作组的调查。
Br J Haematol. 2017 Feb;176(3):431-439. doi: 10.1111/bjh.14428. Epub 2016 Nov 23.
8
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.达雷妥尤单抗用于多发性骨髓瘤异基因造血细胞移植后是安全的，且与预先存在的慢性移植物抗宿主病协同作用。来自CMWP-EBMT的一项回顾性研究。
Bone Marrow Transplant. 2022 Mar;57(3):499-501. doi: 10.1038/s41409-021-01560-y. Epub 2022 Jan 10.
9
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.嗜酸性疾病异基因造血细胞移植的结局：欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的一项回顾性研究
Br J Haematol. 2022 Jul;198(1):209-213. doi: 10.1111/bjh.18219. Epub 2022 Apr 28.
10
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP.在代表 EBMT CMWP 的情况下，1991-2012 年间，接受过先前的自体移植后，异体移植治疗骨髓瘤的条件相关结果。
Eur J Haematol. 2020 Mar;104(3):181-189. doi: 10.1111/ejh.13352. Epub 2019 Dec 25.

引用本文的文献

1
Commentary: Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management.评论：病例报告：与单克隆丙种球蛋白病相关的慢性中性粒细胞白血病。病例系列及遗传特征与实际管理的综述
Front Oncol. 2024 Feb 27;14:1360791. doi: 10.3389/fonc.2024.1360791. eCollection 2024.
2
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.慢性中性粒细胞白血病中附加致病性突变的研究进展。
Ann Hematol. 2024 Aug;103(8):2591-2600. doi: 10.1007/s00277-023-05550-6. Epub 2023 Nov 22.

本文引用的文献

1
A population-based study of chronic neutrophilic leukemia in the United States.美国一项基于人群的慢性嗜中性粒细胞白血病研究。
Blood Cancer J. 2020 Jun 15;10(6):68. doi: 10.1038/s41408-020-0334-1.
2
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.芦可替尼治疗慢性中性粒细胞白血病和不典型慢性髓性白血病患者的疗效。
J Clin Oncol. 2020 Apr 1;38(10):1006-1018. doi: 10.1200/JCO.19.00895. Epub 2019 Dec 27.
3
Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.异基因造血干细胞移植治疗BCR-ABL1阴性非典型慢性髓性白血病和慢性中性粒细胞白血病：日本一项全国性回顾性研究
Leuk Res. 2018 Dec;75:50-57. doi: 10.1016/j.leukres.2018.11.003. Epub 2018 Nov 13.
4
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival.CSF3R 突变型慢性中性粒细胞白血病：19 例连续患者的长期预后及生存风险模型
Blood Cancer J. 2018 Feb 15;8(2):21. doi: 10.1038/s41408-018-0058-7.
5
T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.接受异基因干细胞移植的慢性中性粒细胞白血病和慢性粒单核细胞白血病患者中的T618I突变型集落刺激因子3受体
Ann Lab Med. 2015 May;35(3):376-8. doi: 10.3343/alm.2015.35.3.376. Epub 2015 Apr 1.
6
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.ASXL1 突变在 CSF3R 突变的慢性中性粒细胞白血病中频繁发生且具有预后不良影响。
Am J Hematol. 2015 Jul;90(7):653-6. doi: 10.1002/ajh.24031.
7
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.世界卫生组织定义的慢性嗜中性粒细胞白血病：12例长期分析及文献批判性综述
Leukemia. 2005 Feb;19(2):313-7. doi: 10.1038/sj.leu.2403562.
8
Allogeneic bone marrow transplantation in the management of chronic neutrophilic leukemia.异基因骨髓移植治疗慢性中性粒细胞白血病
Leuk Lymphoma. 2002 Oct;43(10):2051-4. doi: 10.1080/1042819021000016087.
9
Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease.慢性中性粒细胞白血病：14例罕见骨髓增殖性疾病新病例。
J Clin Pathol. 2002 Nov;55(11):862-4. doi: 10.1136/jcp.55.11.862.
10
Chronic neutrophil leukaemia in adolescence and young adulthood.青少年及青年期慢性中性粒细胞白血病
Br J Haematol. 1996 Sep;94(4):628-30. doi: 10.1046/j.1365-2141.1996.7082329.x.